Recent Publications on Karnofsky Performance Status: |  |
Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research.
PURPOSE: To evaluate the effects of palliative chemotherapy with...
Direct Link | 15th August, 2008
| Department of Internal Medicine, Division Oncology/Hematology,
|
Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.
PURPOSE: To compare clinical benefit response (CBR) and quality of life...
Direct Link | 15th August, 2008
| Swiss Group for Clinical Cancer Research Coordinating Center, Bern,
|
| [Successful treatment of non-small cell lung cancer by gefitinib in an elderly patient with poor performance status]
| 13th August, 2008
| Department of Integrated Medicine and Informatics, Ehime University
|
Linear accelerator stereotactic radiosurgery for metastatic brain tumors: 17 years of experience at the University of Florida.
OBJECTIVE: To review one of the largest single-institution experiences...
Direct Link | 13th August, 2008
| Department of Neurosurgery, University of Florida, Gainesville, Florida
|
Parameters assessing neurological status in malignant glioma patients: prognostic value for survival and relapse-free time.
Malignant gliomas are the commonest primary brain tumours in adults and...
Direct Link | 8th August, 2008
| Department of Neurosurgery, Klinikum Fulda, Academic Hospital Philipps
|
Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients.
Introduction: The benefit of cytoreductive surgery for glioblastoma...
Direct Link | 1st August, 2008
| Medac Gesellschaft fur klinische Spezialpraparate mbH, Theaterstr. 6,
|
Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy-Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer.
Objective: To determine clinically meaningful changes (CMCs) for the...
Direct Link | 24th July, 2008
| Center on Outcomes, Research and Education (CORE), Evanston Northwestern
|
Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma.
PURPOSE: We evaluated the prognostic roles of metastasectomy and an...
Direct Link | 19th July, 2008
| Department of Urology and Division of Solid Tumor Oncology, Memorial
|
Surgical treatment for patients with different origins of Krukenberg tumors: Outcomes and prognostic factors.
AIMS: We sought to investigate survival impacts of metastasectomy in women...
Direct Link | 18th July, 2008
| Ovarian Cancer Program, Department of Gynecologic Oncology, Fudan
|
The correlation among patients and health care professionals in assessing functional status using the karnofsky and eastern cooperative oncology group performance status scales.
This study evaluated the correlation between Karnofsky performance status...
Direct Link | 17th July, 2008
| Department of Radiation Therapy, Toronto Sunnybrook Regional Cancer
|
| [Assessment of the quality of life of patients with lung cancer using the Medical Outcomes Study 36-item Short-Form Health Survey]
| 16th July, 2008
| Universidade Federal de Sao Paulo, Sao Paulo, SP, Brasil.
|
The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study.
Lymphoplasmacytic lymphoma (LL) is incurable by standard therapy (median...
Direct Link | 12th July, 2008
| Department of Haematology, Leeds Teaching Hospitals, Leeds, UK.
|
| Survival rate of pancreatic cancer in elderly patients.
| 11th July, 2008
| Department of Oncology, Shanghai Medical College, Shanghai, China.
|
Utility of the "Surprise" Question to Identify Dialysis Patients with High Mortality.
BACKGROUND AND OBJECTIVES: Dialysis patients are increasingly...
Direct Link | 4th July, 2008
| Section of Nephrology, Department of Medicine, School of Medicine, and
|
A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck.
OBJECTIVE: The combination of taxanes and anthracyclines has been proved...
Direct Link | 1st July, 2008
| Division of Oncology and Hematology, Buddhist Tzu-Chi General Hospital,
|
